BeStock  
Stocks › Biotechnology › SNDX

Syndax Pharmaceuticals SNDX

US equityMarket cap rank #3319Biotechnology
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$83.30M+81.6% YoY
Operating profit-$41.90M+27.0% YoY
Net profit-$49.43M+18.6% YoY
Diluted EPS-$0.55+21.4% YoY
Free cash flow-$27.25M+61.4% YoY
Operating cash flow-$27.25M

Revenue, last 8 quarters

$7.7MDec '24$20.0MMar '25$38.0MJun '25$45.9MSep '25$68.7MDec '25$64.9MMar '26$72.8MJun '26$83.3MSep '26

Net profit, last 8 quarters

$-94.2MDec '24$-84.8MMar '25$-71.8MJun '25$-60.7MSep '25$-68.0MDec '25$-42.7MMar '26$-49.4MJun '26$-49.4MSep '26

Diluted EPS by quarter

-1.10Dec '24-0.98Mar '25-0.83Jun '25-0.70Sep '25-0.78Dec '25-0.48Mar '26-0.55Jun '26-0.55Sep '26

Free cash flow by quarter

$-57.4MDec '24$-95.2MMar '25$-87.8MJun '25$-70.7MSep '25$-69.5MDec '25$-50.3MMar '26$-30.3MJun '26$-27.3MSep '26

Annual revenue

$1.5MFY20$139.7MFY21$0.0FY22$0.0FY23$23.7MFY24$172.4MFY25

Profitability & balance sheet

Gross margin92.2%
Operating margin-61.7%
Net margin-72.3%
Return on equity-426.4%
Return on assets-33.7%
Return on invested capital-104.1%
Current ratio4.69
Liabilities / assets102.5%
Cash & investments$427.10M
Total debt$244.79M
Net cash (debt)$182.31M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $83.30M $72.79M $64.86M $172.35M $68.73M
Total Operating Revenue $83.30M $72.79M $64.86M $172.35M $68.73M
Cost of Revenue $14.00M $3.21M $2.63M $6.97M $2.71M
Gross Profit $69.30M $69.58M $62.23M $165.38M $66.02M
Operating Expense $111.20M $109.58M $96.43M $438.47M $128.57M
Selling and Admin Expenses $43.72M $41.54M $37.59M $179.68M $49.93M
-General & Admin Expense $43.72M $41.54M $37.59M $179.68M $49.93M
Research & Development $67.48M $68.04M $58.85M $258.78M $78.64M
Operating Profit -$41.90M -$40.00M -$34.20M -$273.08M -$62.55M
Net Non-Operating Interest Income (Expense) -$7.39M -$8.93M -$8.29M -$11.06M -$5.27M
Non-Operating Interest Income $5.59M $3.75M $3.56M $22.73M $4.33M
Non-Operating Interest Expense $12.98M $12.68M $11.85M $33.79M $9.59M
Other Income (Expense) -$153,000.00 -$438,000.00 -$186,000.00 -$1.28M -$201,000.00
Other Non-Operating Income (Expenses) -$153,000.00 -$438,000.00 -$186,000.00 -$1.28M -$201,000.00
Pretax Profit -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Net Profit -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Profit from Continuing Operations -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Net Income to Parent Company -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Net Income to Common Stockholders -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Basic EPS -$0.55 -$0.55 -$0.48 -$3.29 -$0.78
Diluted EPS -$0.55 -$0.55 -$0.48 -$3.29 -$0.78

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $692.67M $703.65M $472.67M $529.71M $529.71M
Total Current Assets $567.44M $675.04M $471.18M $528.08M $528.08M
Cash and Cash Equivalents & Short-Term Investments $427.10M $547.86M $352.06M $394.07M $394.07M
-Cash and Cash Equivalents $135.94M $336.48M $130.89M $134.93M $134.93M
-Short Term Investments $291.16M $211.38M $221.17M $259.14M $259.14M
Receivables $79.78M $72.79M $60.69M $70.29M $70.29M
-Accounts Receivable $46.87M $45.07M $38.12M $38.00M $38.00M
-Accrued Interest Receivable $3.07M $2.66M $1.80M $2.15M $2.15M
-Other Receivables $29.85M $25.06M $20.77M $30.15M $30.15M
Prepaid Assets $18.22M $18.81M $21.20M $29.75M $29.75M
Inventory $39.38M $33.16M $34.95M $32.75M $32.75M
Other Current Assets $2.95M $2.42M $2.27M $1.22M $1.22M
Total Non-Current Assets $125.24M $28.61M $1.49M $1.63M $1.63M
Net PPE $1.16M $1.29M $1.39M $1.52M $1.52M
-Gross PPE $1.60M $1.73M $1.82M $1.95M $1.95M
-Accumulated Depreciation -$440,000.00 -$434,000.00 -$429,000.00 -$425,000.00 -$425,000.00
Investments and Advances $123.98M $27.22M – $0.00 $0.00
-Available for Sale Securities $123.98M – – – –
Other Non-Current Assets $102,000.00 $102,000.00 $102,000.00 $102,000.00 $102,000.00
Total Liabilities $709.85M $688.55M $431.05M $465.08M $465.08M
Total Current Liabilities $120.96M $99.68M $86.17M $120.12M $120.12M
Payables $12.91M $13.06M $18.30M $23.95M $23.95M
-Accounts Payable $3.57M $4.87M $10.84M $16.58M $16.58M
-Other Payable $9.34M $8.18M $7.46M $7.37M $7.37M
Current Accrued Expenses $79.69M $62.07M $49.18M $60.81M $60.81M
Short-Term Debt and Capital Lease Obligation $526,000.00 $506,000.00 $488,000.00 $472,000.00 $472,000.00
-Current Capital Lease Obligation $526,000.00 $506,000.00 $488,000.00 $472,000.00 $472,000.00
Current Provisions $11.71M $11.12M $10.11M $9.81M $9.81M
Other Current Liabilities $1.96M $1.55M $1.27M $721,000.00 $721,000.00
Total Non-Current Liabilities $588.89M $588.88M $344.87M $344.96M $344.96M
Long Term Debt and Capital Lease Obligation $244.79M $244.85M $907,000.00 $1.05M $1.05M
-Long Term Debt $244.19M $244.09M $343.97M $343.91M $343.91M
-Long Term Capital Lease Obligation $607,000.00 $760,000.00 $907,000.00 $1.05M $1.05M
Other Non-Current Liabilities $344.10M $344.03M $343.97M $343.91M $343.91M
Total Equity -$17.18M $15.10M $41.62M $64.63M $64.63M
Stockholders' Equity -$17.18M $15.10M $41.62M $64.63M $64.63M
Capital Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Common Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
Additional Paid-In Capital $1.63B $1.61B $1.59B $1.57B $1.57B
Retained Earnings -$1.65B -$1.60B -$1.55B -$1.51B -$1.51B
Gains/Losses Not Affecting Retained Earnings -$1.67M -$140,000.00 $11,000.00 $452,000.00 $452,000.00
-Preferred Stock – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$27.25M -$30.27M -$50.35M -$322.98M -$69.49M
Net cash flow from continuing operations -$27.25M -$30.27M -$50.35M -$322.98M -$69.49M
Net Income from Continuing Operations -$49.43M -$49.36M -$42.67M -$285.42M -$68.01M
Depreciation & Depletion & Amortization $6,000.00 $5,000.00 $4,000.00 $6,000.00 $3,000.00
Other Non-Cash Items $1.47M $988,000.00 $186,000.00 $1.34M $557,000.00
Change in Working Capital $7.01M $4.79M -$19.05M -$79.32M -$11.76M
-Change in Receivables $207,000.00 -$9.39M $6.02M -$79.81M -$61.97M
-Change in Inventory -$6.02M $1.84M -$2.06M -$32.09M -$7.80M
-Change in Prepaid Assets -$354,000.00 $1.39M $7.84M -$14.54M -$5.40M
-Change in Payables and Accrued Expense $19.97M $12.80M -$34.09M $47.12M $28.45M
-Change In Other Working Capital -$6.79M -$1.85M $3.24M – –
Net cash flow from investing -$176.47M -$16.91M $38.39M $290.04M $81.58M
Net Cash Flow from Continuing Investing Activities -$176.47M -$16.91M $38.39M $290.04M $81.58M
Net PPE Purchase and Sale $0.00 – – -$187,000.00 -$56,000.00
Net Investment Purchase and Sale -$176.47M -$16.87M $38.39M $290.22M $81.63M
Financing Cash Flow $3.19M $252.77M $7.92M $13.68M $5.92M
Net Cash Flow from Continuing Financing Activities $3.19M $252.77M $7.92M $13.68M $5.92M
Net Issuance Payments Of Debt $0.00 – – – –
Proceeds from Stock Option Exercised $3.20M $8.92M $7.92M $13.68M $5.92M
Net Other Financing Charges -$13,000.00 – – – –
Ending Cash Balance $136.04M $336.58M $131.00M $135.03M $135.03M
Net Change in Cash -$200.54M $205.58M -$4.04M -$19.27M $18.01M
Beginning Cash Balance $336.58M $131.00M $135.03M $154.30M $117.03M
Free Cash Flow -$27.25M -$30.31M -$50.35M -$323.17M -$69.54M
-Change in Other Current Assets – – – $0.00 $0.00
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on SNDX.

Sign in to join the discussion.

Scroll to Top